Newly diagnosed with
Type 1 Diabetes (T1D)?
There is hope for a healthier future
We are seeking
volunteers
to participate
in a clinical study
Living with Type 1 Diabetes (T1D)
We know that living with T1D is hard. Managing your diabetes is a 24-hour job with no breaks. Your blood sugar is affected not just by the food you eat, but also by many other factors such as exercise, stress, hormones, and even the weather! And the risk of complications is real.
Did you know?
- Most people diagnosed with T1D do not have a family history of the disease
- Over half of new T1D diagnoses are in people ages 20 and older
- T1D is not caused by lifestyle, diet or being overweight
- T1D affects people of all races, ethnicities, ages, and socioeconomic backgrounds
A clinical study that engineers your cells to slow or stop the progression of your T1D.
What is the Polaris Study?
The POLARIS Study is a one-time treatment that takes your own cells and engineers them to counteract the autoimmune process which may slow or stop the progression of your T1D.
For more study details, visit:
ClinicalTrials.gov – NCT06919354
For more study details, visit:
ClinicalTrials.gov – NCT06919354
Can I Participate?
- An adult aged 18-45
- Newly diagnosed with T1D
- May be taking insulin
- Other than T1D, in good health
What is GNTI-122?
GNTI-122 is an investigational cell therapy manufactured from your own blood cells that intends to correct an imbalance of certain types of cells found in people with T1D. Correcting this imbalance may help slow down or stop worsening of T1D.
To find out if the POLARIS Study is right for you, please discuss it with your doctor or CONTACT US.
Clinical Study Sites
If you would like to learn more about this study, contact the closest study site for more information.
NOW RECRUITING
University of North Carolina at Chapel HillChapel Hill, NC
uncdiabetes@med.unc.edu
+1 984.974.3004
Future Recruitment Sites
University of California San FranciscoSan Francisco, CA
clinicalresearch@diabetes.ucsf.edu
+1 844.813.8273
University of Florida
Gainesville, FL
jennifer.hosford@peds.ufl.edu
+1 352.294.5759
University of Miami
Diabetes Research Institute
Miami, Fl
cblaschke@miami.edu
+1 305.243.4485
City of Hope
Duarte, CA
islets@coh.org
+1 866.444.7538
Icahn School of Medicine at Mount Sinai
New York, NY
camilla.levister@mssm.edu
+1 212.241.5177
Joslin Diabetes Center
Boston, MA
T1DTrials@joslin.harvard.edu
+1 888.813.8669
University of California San Diego
La Jolla, CA
T1hughes@health.ucsd.edu
+1 858.905.0698
Duke University
Durham, NC
megan.reaves@duke.edu
+1 919.660.2272
Boston, MA
T1DTrials@joslin.harvard.edu
+1 888.813.8669
University of California San Diego
La Jolla, CA
T1hughes@health.ucsd.edu
+1 858.905.0698
Duke University
Durham, NC
megan.reaves@duke.edu
+1 919.660.2272
Participating in clinical studies is voluntary. You have the right not to participate, or to end your participation in the clinical study at any time.